Chemical Engineering in Indiana

📊 Employment Overview

Indiana employs 620 chemical engineering professionals, representing approximately 2.0% of the national workforce in this field. Indiana ranks #17 nationally for chemical engineering employment.

💰 Salary Information

Chemical Engineering professionals in Indiana earn competitive salaries across all experience levels, with an average annual salary of $99,000.

Note: Salaries are adjusted for cost of living and local market conditions. Data based on BLS statistics and industry surveys (2024-2025).

🎓 Schools Offering Chemical Engineering

Loading school data...

🚀 Career Insights

Key information for chemical engineering professionals in Indiana.

🏢 Industry Landscape & Top Employers

Indiana's chemical engineering sector is shaped by the extraordinary concentration of pharmaceutical and life sciences manufacturing that has made the state one of the nation's most significant pharmaceutical process engineering markets — ranking #17 nationally with 620 employed chemical engineers and a $99,000 average salary. Eli Lilly's Indianapolis headquarters and global manufacturing presence, combined with the Cook Medical and Roche Diagnostics ecosystems and a significant polymer and specialty chemicals manufacturing base, create chemical engineering career pathways in Indiana that rival much larger markets in pharmaceutical process sophistication.

Major Employers — Pharmaceuticals: Eli Lilly and Company — headquartered in Indianapolis since 1876 and now one of the world's most valuable pharmaceutical companies — is Indiana's defining chemical engineering employer. Lilly's drug substance manufacturing at its Branchburg, NJ and Indianapolis facilities (including biologics, small molecule API synthesis, and drug product manufacturing) and its massive investment in manufacturing capacity for tirzepatide (Mounjaro/Zepbound) GLP-1 agonist creates sustained chemical engineering demand at a company that is simultaneously managing an extraordinary commercial success and a manufacturing scale-up challenge. Roche Diagnostics' Castleton facility, Dow AgroSciences (now Corteva, headquartered in Indianapolis), and a growing cluster of pharmaceutical CDMOs and contract manufacturers in the Indianapolis and Zionsville corridors extend the pharmaceutical ChE employer base.

Major Employers — Chemicals and Materials: Dow Chemical's Indiana operations, INEOS's Indiana polymer manufacturing, and the petrochemical supply chain serving Indiana's manufacturing sector employ process chemical engineers. Calumet Specialty Products (Indianapolis) produces specialty hydrocarbons, lubricants, and solvents at its Indianapolis refinery — one of the few specialty hydrocarbon refineries remaining in the Midwest. The steel industry's chemical byproduct processing (coking chemical recovery, blast furnace gas processing) at Indiana's Gary-Burns Harbor steel complex employs process engineers at the intersection of metals and chemicals processing.

Agricultural Chemistry: Corteva Agriscience's Indianapolis headquarters employs chemical engineers in crop protection chemistry, herbicide and insecticide formulation process development, and seed treatment chemical manufacturing. Indiana's significant agricultural processing sector — with ethanol plants across the Corn Belt, soybean crushing operations, and specialty food ingredient producers — creates additional process engineering employment in the agricultural chemicals value chain.

Key Industry Clusters: Indianapolis and its northern suburbs (Zionsville, Carmel, Fishers) concentrate pharmaceutical manufacturing and corporate R&D engineering. Northwest Indiana's Gary-Hammond-East Chicago steel and petrochemical corridor represents the state's traditional heavy industrial ChE base. Lafayette's Purdue University engineering programs and adjacent pharmaceutical and manufacturing employers create a university-industrial corridor with strong talent pipeline alignment.

📈 Career Growth & Pathways

Indiana chemical engineering careers are increasingly shaped by Eli Lilly's extraordinary growth trajectory — the GLP-1 agonist market's commercial success is driving one of the most significant pharmaceutical manufacturing capital investment programs in US history, creating sustained high-quality chemical engineering demand in Indianapolis.

• Entry-Level Engineer (0–2 years): $63,000–$80,000 — Eli Lilly's new-grad process engineering programs are Indiana's most competitive entry paths. Purdue University's top-10 ranked ChE program and Rose-Hulman Institute of Technology produce excellent graduates. Corteva Agriscience's process chemistry programs and Calumet Specialty Products' refinery engineering roles provide alternative entry points.
• Mid-Level Engineer (3–7 years): $85,000–$112,000 — Lilly process development engineer on tirzepatide API synthesis or drug product manufacturing, Corteva herbicide formulation process development specialist, or specialty hydrocarbons process engineer at Calumet's Indianapolis refinery. Total compensation at Lilly including bonus is meaningfully above base for engineers on commercial manufacturing programs.
• Senior Engineer (8–14 years): $115,000–$140,000 — Lilly principal scientist in process development with CMC regulatory filing experience, Corteva global process technology director, or Calumet technical director for specialty hydrocarbon product lines. Lilly's tirzepatide manufacturing scale-up is creating senior process engineering roles with global manufacturing oversight responsibility at the state's most commercially significant employer.
• Director / Fellow (15+ years): $143,000–$230,000+ — Lilly's Executive Director of Manufacturing Sciences, Corteva's VP of Global Supply, or senior research faculty at Purdue's Davidson School of Chemical Engineering.

Lilly's GLP-1 Manufacturing Scale-Up: Eli Lilly's commitment to manufacturing tirzepatide (Mounjaro for diabetes, Zepbound for obesity) at the scale required by global demand represents one of the largest API and drug product manufacturing investments in pharmaceutical history. The chemical synthesis of tirzepatide — a large peptide molecule requiring sophisticated solid-phase synthesis or solution-phase chemistry at commercial scale — is an extraordinary process engineering challenge. Lilly is investing billions in manufacturing capacity expansion that requires chemical engineers in process development, manufacturing technology transfer, and commercial manufacturing operations for years to come. Indiana-based Lilly process engineers working on this program are at the center of one of the most consequential pharmaceutical manufacturing challenges of the decade.

💰 Salary vs. Cost of Living

Indiana's $99,000 average chemical engineering salary is near the national median and is paired with one of the Midwest's lowest costs of living — creating strong purchasing power particularly in the pharmaceutical-dominated Indianapolis market and the Purdue corridor.

Indianapolis Metro: Indiana's ChE salary leader. Lilly and pharmaceutical employers pay experienced engineers $100,000–$165,000+. Indianapolis's cost of living is approximately 5–10% below the national average, with median home prices of $260,000–$380,000 in quality suburbs (Carmel, Fishers, Zionsville, Greenwood). A senior Lilly process engineer earning $140,000 in Zionsville achieves purchasing power roughly equivalent to $200,000–$215,000 in New Jersey's pharmaceutical corridor — enabling aggressive wealth building on a pharmaceutical career timeline that coastal pharma employees cannot match.

West Lafayette / Purdue: University-influenced market where Purdue research positions and nearby pharmaceutical employers pay $80,000–$120,000 against Tippecanoe County housing (median $260,000–$350,000) that is among the most affordable university city markets in the Big Ten.

Northwest Indiana (Gary / Hammond): The traditional heavy industrial corridor offers $85,000–$120,000 for experienced process engineers at steel and chemical facilities against one of Indiana's most affordable housing markets (median $180,000–$270,000). The tradeoff is the region's urban challenges relative to Indianapolis's suburban quality.

State Income Tax: Indiana's flat 3.15% income tax (one of the nation's lowest) is a meaningful financial advantage — at a $120,000 salary, the annual savings versus a 5% flat rate state amount to approximately $2,200, and versus California's marginal rates, the differential is dramatically larger.

📜 Licensing & Professional Development

Engineering licensure in Indiana is administered by the Indiana Professional Licensing Agency (IPLA). Indiana has a streamlined NCEES-aligned process with full reciprocity — Indiana-Ohio and Indiana-Illinois dual licensure is common for engineers serving the broader Midwest manufacturing corridor.

Indiana PE Licensure Path: Standard NCEES FE → 4 years experience → PE exam. Purdue's ChE program produces extremely well-prepared PE exam candidates. Indiana's low income tax makes establishing permanent Indiana licensure financially attractive for engineers building long-term careers in the state.

Pharmaceutical Manufacturing Credentials: For Lilly and Indiana's pharmaceutical ChE community, FDA cGMP expertise (21 CFR Parts 210/211), ICH Q11 (drug substance manufacturing and development), and the specific regulatory frameworks for peptide drug substance manufacturing (which combine elements of traditional API synthesis regulation and biologics manufacturing oversight) are the most career-critical professional development areas. As Lilly's tirzepatide manufacturing grows, chemical engineers with expertise in large-scale peptide synthesis — including solid-phase synthesis scale-up, Fmoc chemistry process safety, and peptide purification by preparative HPLC — are developing credentials of extraordinary scarcity and value.

Corteva / Agricultural Chemistry: EPA pesticide registration chemistry knowledge (FIFRA regulatory framework), formulation chemistry certification through Croplife America's technical programs, and AIChE's Agricultural and Food Process Engineering Division programming are relevant professional development resources for Indiana's agricultural chemistry ChE community.

📊 Job Market Outlook

Indiana's chemical engineering market is on a strong growth trajectory, driven almost entirely by Eli Lilly's historic manufacturing scale-up program for GLP-1 agonist therapies and the broader pharmaceutical manufacturing investment that Indiana's pro-business environment is attracting.

Lilly's $9+ Billion Manufacturing Investment: Eli Lilly has publicly committed to over $9 billion in manufacturing capacity expansion at its Indiana facilities and globally, specifically to produce tirzepatide and next-generation GLP-1 agonist therapies at the scale that obesity medicine's commercial success demands. This investment — adding manufacturing capacity for both the API (the peptide drug substance) and the drug product (the autoinjector pen devices containing the formulated drug) — will directly create hundreds of chemical engineering positions in process development, manufacturing technology transfer, quality systems, and commercial manufacturing operations over the next 5–7 years.

Pharmaceutical CDMO Growth: Indiana's pharmaceutical manufacturing infrastructure and Purdue's talent pipeline are attracting contract development and manufacturing organizations (CDMOs) to establish or expand Indiana operations. Covington Biomedical, AMRI (now Curia), and several smaller CDMOs serve Indiana pharmaceutical manufacturers and the broader Midwest pharma market from Indiana facilities, creating additional ChE positions that complement Lilly's direct hiring.

5-Year Projection: Indiana chemical engineering employment is projected to grow 13–18% over five years — driven overwhelmingly by Lilly's manufacturing expansion. Total employment could approach 714–732 by 2029.

🕐 Day in the Life

Chemical engineering in Indiana is shaped by the pharmaceutical industry's demanding quality culture and the Midwest's genuine work-life balance orientation — creating a professional environment that combines world-class technical challenges with personal financial security and community stability that pharmaceutical engineers at coastal companies often envy.

At Eli Lilly (Indianapolis / Branchburg): A process development engineer working on Lilly's tirzepatide manufacturing program is participating in one of the pharmaceutical industry's most consequential and technically demanding projects. A morning begins with reviewing scale-up data from the previous week's 100-liter solid-phase peptide synthesis run — examining the coupling efficiency at each amino acid addition step, comparing the resin loading density to the 10-liter development scale, and analyzing the peptide cleavage and deprotection step's yield and impurity profile. The scale-up from bench to commercial manufacturing for a large peptide involves solving heat transfer, mass transfer, and solvent handling challenges that don't arise at laboratory scale — and solving them under FDA cGMP manufacturing requirements that demand documented evidence of every decision. Afternoon involves a technology transfer meeting with Lilly's manufacturing site team — preparing the process description documents that will guide the manufacturing engineers who will operate the commercial process, ensuring that every critical process parameter's rationale is documented and the acceptable operating range is validated with experimental evidence. The professional significance of this work — the manufactured drug will be injected by millions of patients managing diabetes or obesity — creates a purpose orientation that Lilly engineers consistently describe as one of their career's most motivating dimensions.

Lifestyle: Indianapolis offers a quality-of-life proposition that pharmaceutical engineers relocating from New Jersey or California consistently rate above initial expectations. The Indianapolis Motor Speedway's month-long May tradition, the Pacers and Colts' professional sports culture, Monument Circle's vibrant downtown, the Cultural Trail cycling and pedestrian corridor, and the Virginia Avenue arts district create an urban character of genuine vitality. Indiana's affordability — homeownership achievable in the first years of a Lilly career, in communities with excellent schools, short commutes, and generous living space — enables the financial security and family stability that many pharmaceutical engineers from higher-cost markets pursue but cannot achieve on comparable gross salaries.

🔄 Compare with Other States

See how Indiana compares to other top states for chemical engineering: